NYC startups raise $8.88B in Q2 2026, best quarter since 2021

Key Takeaways

• NYC startups raised $8.88B across 233 deals in Q2 2026, up 46% year-over-year
• 24 mega-rounds captured 63% of all capital while representing only 10% of deals
• June 2026 was the largest single funding month in AlleyWatch's history, with NYC capturing 24.4% of all US venture dollars

New York City startups raised $8.88 billion across 233 deals in Q2 2026. That's a 46% surge in capital compared to the same quarter last year, and the strongest second quarter in the city's venture history. June alone broke records as the largest single funding month AlleyWatch has ever tracked.

The headline number tells one story. The structure beneath it tells another. Capital jumped 46% while deal volume rose just 2%. This wasn't a broad funding boom. It was a market where round sizes ballooned at the top while seed and early-stage activity stayed flat.

Where did the money actually go?

Twenty-four NYC startups raised $100 million or more. That cohort absorbed 63% of all capital deployed in Q2, despite accounting for just 10% of deals. The top 10 companies alone claimed 43% of total funding.

For founders outside that elite tier, Q2 2026 was healthy but unremarkable. For late-stage companies with proven AI-era revenue models and institutional distribution channels, it was historic.

Ramp led the quarter with a $750 million Series F at a $44 billion valuation. VAST Data closed a $500 million Series F for its AI data infrastructure platform. Modal Labs raised $355 million for AI cloud infrastructure. The pattern is clear: investors are writing massive checks for companies building the picks and shovels of the AI stack.

How did each month perform?

April opened steady. Capital grew 27.7% year-over-year on stable deal volume, signaling expanding round sizes rather than a broader surge. VAST Data's $500 million round anchored the month.

May showed unusual breadth. Seven companies raised $100 million or more. Four of the top 10 deals went to health and insurance technology companies: Vi Labs, Reserv, Garner Health, and Nourish collectively raised $471 million. This marked a quiet but significant shift of late-stage capital toward health-sector AI applications.

June shattered records. NYC captured 24.4% of all US venture dollars, its highest national share ever recorded. Twelve companies closed $100 million or more rounds. The city's average deal size hit $58.1 million, running 29% above the national average. Its $15 million median was nearly double the US figure.

Is NYC becoming an AI research hub?

Here's the real shift. New York has not historically built frontier AI models. That work concentrated in San Francisco. Until now.

Two pure research labs closed mega-rounds in June. Flourish emerged from stealth with $500 million, backed by Jeff Bezos, Lux Capital, and GV, to build brain-inspired AI systems. General Intuition closed its own mega-round the same month. For the first time, foundational model development has planted roots in New York.

This matters because it changes the city's position in the AI value chain. NYC has long excelled at the application layer, the infrastructure tooling, the fintech use cases. Now it's adding the foundational research that feeds those applications.

What's driving the global context?

NYC's surge sits inside a broader global recovery. Crunchbase reports that Q2 2026 marked the highest quarterly funding level since the 2021 peak. AI companies captured the majority of the ten largest rounds worldwide.

J.P. Morgan's Q2 2026 Venture Capital Monitor notes that AI-related investments now account for the largest share of VC dollars deployed in any single technology category in the fund's tracking history.

The US market also benefited from geopolitical tailwinds. European and Asian LPs diversified into US funds, and the relative depth of the American LP base compounded that capital inflow.

What does this mean for founders raising now?

The numbers contain a warning alongside the optimism. Capital concentration at the top means the market is bifurcating. Late-stage companies with clear AI revenue models are swimming in liquidity. Early-stage founders face a market that's healthy, not hot.

If you're building in AI infrastructure, health-tech AI applications, or fintech at scale, NYC's investor base is writing checks at historic levels. If you're at seed stage, expect competition for attention. The mega-rounds are absorbing partner bandwidth.

Frequently Asked Questions

How much did NYC startups raise in Q2 2026?

NYC startups raised $8.88 billion across 233 deals in Q2 2026, representing a 46% year-over-year increase in capital.

Which NYC startup raised the most in Q2 2026?

Ramp led with a $750 million Series F at a $44 billion valuation. VAST Data and Flourish each raised $500 million.

What percentage of NYC funding went to mega-rounds?

Twenty-four companies raising $100 million or more captured 63% of all Q2 capital while representing just 10% of deals.

Is NYC becoming an AI research hub?

Yes. For the first time, frontier AI research labs like Flourish and General Intuition closed mega-rounds in New York, moving foundational model development beyond San Francisco.

What was special about June 2026 for NYC startups?

June 2026 was the largest single funding month in AlleyWatch's history. NYC captured 24.4% of all US venture dollars, its highest national share on record.

Source: AlleyWatch